IRADIMED CEO Executes Rule 10b5-1 Stock Sales Totaling Over $642,000
Roger E. Susi, who serves as the CEO, President, and Chairman of IRADIMED CORP (NASDAQ: IRMD), has completed a series of stock transactions totaling 7,500 shares of common stock. The sales, which yielded a total value of $642,861, were executed over two days in early May 2026. These transactions were carried out under a pre-established Rule 10b5-1 …